Nitrogen fixation in Klebsiella pneumoniae requires expression of at least 15 genes arranged in seven operons that constitute the nifcluster (1, 2) . The protein products of most of these genes have been identified and functions have been assigned to them (3) (4) (5) (6) (7) (8) .
Molybdenum in dinitrogenase (EC 1.18.6. 1) (component I) is present in a cofactor (iron-molybdenum cofactor, FeMoco) containing Fe, Mo, and S (9) . FeMo-co has been proposed as the active site for the reduction of N2, since it restores the activity of certain non-nitrogen-fixing (Nif-) mutants (4, 9) , gives dinitrogenase its characteristic electron paramagnetic resonance (EPR) spectrum, which changes during enzyme turnover (10, 11) , and can catalyze acetylene reduction to ethylene (12) . Azotobacter vinelandii strain UW45, a mutant lacking FeMo-co, has been used extensively to study the cofactor (13) . In the best-studied nitrogen-fixing organism, K. pneumoniae, the products of at least six genes (other than the two required for structural proteins of dinitrogenase) are required for the synthesis of active dinitrogenase. The genes mol (equivalent to chlD of Escherichia coli) and nifQ are required for maximum nitrogen fixation (7, (14) (15) (16) . Mutations in these genes affect early steps in Mo metabolism leading to the synthesis of FeMo-co (7, 14, 15) . Like NifQ-and ChIDstrains, NifV-strains showed high levels of acetylenereducing activity both in vivo and in vitro (4) . The NifVstrains efficiently reduce acetylene but not N2 (17) . Recently, it has been suggested that the nifV gene product is involved in the final modification of FeMo-co (18, 19) . Modification of FeMo-co by the nifj gene product is claimed to be essential for efficient nitrogen fixation (18, 19) . Mutants with lesions in the genes nifB, nifN, and niJE synthesize a cofactorless dinitrogenase that can be activated in vitro by the addition of FeMo-co (4, 9, 20) . The protein products of these genes have been identified (4, 8) , but there is no information about the processes that they catalyze. Recently, it was shown that biosynthesis of FeMo-co does not require the presence of dinitrogenase subunit proteins (20) . In the absence of dinitrogenase structural proteins, FeMo-co accumulates on a different protein, presumably involved in the FeMo-co biosynthesis (20) . Very little is known about the pathway of biosynthesis of FeMo-co and its insertion into dinitrogenase. This paper reports conditions for molybdate-dependent in vitro synthesis of FeMo-co and reconstitution of nitrogenase activity.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions. K. pneumoniae mutant strains UN1655 (nijB4691), UN1688 (nifN4724), UN1100 (nifE4420::Mu), UN1089 (nifD4409::Mu), and UN1661 (nifD4697) have been described (21) . A. vinelandii mutant strains UW45, UW10, UW6, and UW38 have been described previously (13, (22) (23) (24) . A. vinelandii strain CA30, a mutant that can be activated in vitro upon addition of FeMo-co, was kindly provided by P. E. Bishop. Growth and derepression of nitrogenase in mutant strains of K. pneumoniae (6, 7) and A. vinelandii (22, 25) have been described previously. When molybdenum-free medium was required, Na2MoO4 was omitted, ultrapure chemicals were used, and all glassware was treated with 4 M HCO and washed with glass-distilled water (7) . Molybdenum-free media were prepared in glass-distilled water. When stated, mutant strains of K. pneumoniae and A. vinelandii were derepressed for nitrogenase synthesis in the presence of 50 gM and 1 mM tungstate, respectively (20) . Cultures for tungsten growth experiments were prepared by at least two cycles of growth in molybdenum-free medium, containing 28 mM ammonium acetate, to deplete intracellular molybdenum (7, 26) .
Preparation of Crude Extracts. All buffers used throughout the procedure were sparged with purified nitrogen for approximately 30 min. These buffers were further deoxygenated on a gassing manifold by repeated evacuation and flushing with argon (purified through a heated copper catalyst) with constant mixing (6) . These buffers contained 1.7 mM sodium dithionite, added just before use.
K. pneumoniae cells were suspended in 0.1 M Tris HCl buffer, pH 7.4, at 1 g of cell paste per 2 ml of buffer containing 5-10 ,ug 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. min at 0-40C under an argon atmosphere (6) . The supernatant solution was transferred to an argon-filled bottle with a syringe rinsed with anaerobic buffer and flushed with argon. The crude extract was stored at -20'C. Extracts from A. vinelandii mutant strains were prepared by osmotic shock (25) .
ATP-Generating System. The ATP-generating system (25) contained 4.2 mM ATP, 50 mM phosphocreatine, 8 30 min, unless otherwise specified. After this incubation, 800 ,ul of ATP/dithionite and 20 ,ul of purified dinitrogenase reductase (30 ,g of protein) were injected in each vial. The vials were brought to atmospheric pressure by piercing the serum stopper with a hypodermic needle, 0.5 ml of acetylene was injected, and the vials were incubated with shaking at 30°C for 15 min. The reaction was terminated by injecting 0.1 ml of 4 M NaOH, and the ethylene formed was measured with a Packard gas chromatograph with a Porapak N (Waters Associates) column (6) .
Nitrogen reduction (25) and anaerobic column chromatography (27) have been described previously. Protein concentrations were determined by the method of Bradford (28) , using serum albumin as a standard. Dinitrogenase (27) and FeMo-co (9) were purified as described in the references. Dinitrogenase reductase from the second DEAE-cellulose column (27) was further purified by passage through a Sephadex G-100 column (2.5 x 86 cm) in 0.1 M NaCl in 25 mM Tris HCl buffer, pH 7.4. EPR spectroscopy was performed as reported (10, 11) , at microwave frequency of 9.27 GHz and with modulation frequency of 100 kHz. Samples were maintained at 26K with liquid helium boil-off for cooling.
ATP, phosphocreatine, hexokinase, glucose-6-phosphate dehydrogenase, glycerol, Tris base, and deoxyribonuclease I were obtained from Sigma. Creatine kinase was obtained from Miles Laboratories. DEAE-cellulose was a Whatman DE-52 (microgranular) product. Ultrapure molybdate and tungstate were obtained from Research Organic/Inorganic Chemical (Sun Valley, CA). All other chemicals were of ultrapure or analytical grade available commercially.
FeMo-co were mixed and incubated for 30 min before the acetylene-reduction assay was initiated by injecting ATP/ dithionite and acetylene, substantially more activity was observed in certain combinations ( Table 1) . Extracts of UN1688 (NifN-) and UN1100 (NifE-) mutants of K. pneumoniae generated significant activity when mixed with extracts of A. vinelandii strains UW45 or CA30. On the other hand, extracts of UN1655 (NifB-) failed to complement UW45 or CA30 extracts. Extracts of A. vinelandii mutants UW45 and CA30 did not complement with each other. Our results suggest that A. vinelandii strain UW45 and CA30 are defective in the gene equivalent to nifB of K. pneumoniae.
Requirements for FeMo-co Synthesis. Pienkos et al. (26) reported that inactive dinitrogenase in wild-type A. vinelandii derepressed for nitrogenase synthesis in the presence of tungstate could be activated in vitro by molybdate and ATP. However, they could not activate inactive dinitrogenase by adding molybdate and ATP to the extracts of UW45. We were also unable to activate inactive dinitrogenase by molybdate and ATP/dithionite in the extracts of FeMo-co-negative mutants of either NifB-, NifN-, or NifE-K. pneumoniae strains or A. vinelandii (UW45 and CA30). On the other hand, addition of molybdate and ATP/dithionite to the mixture of extracts of UW45 (NifB-) and UN1100 (NifE-) generated substantial activity (Table 2) . Similar results were obtained with a mixture of UW45 (NifB-) and UN1688 (NifN-), while UW45 plus UN1655 (NifB-) failed to generate activity. Our results demonstrate that the complementation of UW45 extract with the nifB gene product is essential for molybdateand ATP-dependent synthesis of FeMo-co in vitro. It can be seen from the data that omission of any one of the components of the assay system eliminated the ability to generate FeMo-co activity ( the data presented above, it is not possible to judge whether it is K. pneumoniae orA. vinelandii dinitrogenase deficient in FeMo-co, or both, that is being activated by FeMo-co synthesized in vitro. To resolve this, we used K. pneumoniae and A. vinelandii strains with mutations in the structural genes of dinitrogenase (21, 24) . Dinitrogenase in these mutants cannot be activated by FeMo-co in vitro (4, 13, 20) . These mutants synthesize FeMo-co in vivo (ref. 20; unpub- lished data) and thus should supply nifB, nifN, and niJE products in vitro. To overcome the problem of preformed FeMo-co in these mutants, we derepressed them in the medium containing tungstate instead of molybdate (13, 20, 26 (26, (30) (31) (32) (33) . We examined the effect of tungstate on molybdate-dependent synthesis of FeMo-co in vitro ( Table 5) . Addition of 100 nmol of tungstate to the reaction mixture did not significantly inhibit molybdate (10 nmol)-dependent FeMo-co synthesis. Approximately 33% activity was still observed even after adding a 100-fold excess of tungstate (1 ,mol) to the FeMo-co synthesis reaction. These data show that molybdate is preferentially utilized for Proc. Natl. Acad. Sci. USA 83 (1986) 1639 14; unpublished data). Therefore, the discriminatory step does not occur during transport. It seems that the enzyme(s) involved in FeMo-co synthesis metabolizes molybdate preferentially over tungstate. Approximately 68% activity was still observed even after adding 100-fold excess of vanadate (1 ,umol) to the FeMo-co synthesis reaction, while the same amount of sulfate did not inhibit the reaction.
Effect of Tetrathiomolybdate and Chloramphenicol on Molybdate-Dependent FeMo-co Synthesis. Tetrathiomolybdate is known to block the FeMo-co binding to FeMo-codeficient dinitrogenase (34) . Addition of 25 nmol of tetrathiomolybdate to the FeMo-co synthesis reaction mixture inhibited FeMo-co synthesis by 85%. Even after the addition of 25 nmol of tetrathiomolybdate to these reaction mixtures, FeMo-co-activatable dinitrogenase remained that could be activated by FeMo-co. If FeMo-co synthesis had not been affected by tetrathiomolybdate, 80-90o activity would have been observed in these assays. Thus, it seems that the reaction(s) for FeMo-co synthesis is sensitive to inhibition by tetrathiomolybdate.
Chloramphenicol, but not tetracycline, prevented molybdate-dependent restoration of nitrogenase activity in K. pneumoniae in vivo (35) . The authors suggested that the inhibition by chloramphenicol may be a specific effect on molybdate uptake or processing by the cell. Addition of 200 Ag of chloramphenicol to the FeMo-co synthesis reactions did not inhibit molybdate-dependent synthesis of FeMo-co activity.
Partial Purification and Characterization of Dinitrogenase Activated by FeMo-co Synthesized in Vitro. To isolate and characterize active dinitrogenase, the FeMo-co synthesis reaction (identical to the complete system reported in Table   2 ) was carried out with 8 ml of extract from each mutant. The ATP-generating system was omitted from the control experiment, and glucose (100 ,umol) and hexokinase (25 units) were added to eliminate ATP present in the extracts. The reaction (18, 19) . From our data, it seems that any such modification of FeMo-co by the nijV gene product occurs during the synthesis ofFeMo-co in vitro.
Dinitrogenase fraction from the control experiment (carried out without ATP-generating system) showed less than 2% acetylene-reduction activity compared to dinitrogenase activated by FeMo-co synthesized in the presence of the ATP-generating system. Therefore, ATP is required for FeMo-co synthesis. Pienkos et al. (26) had reported the requirement of ATP for molybdate-dependent activation of inactive dinitrogenase in extracts of A. vinelandii wild-type derepressed in the presence of tungstate instead of molybdate.
Dinitrogenase fractions from both the columns were also analyzed by EPR spectroscopy (10, 11) . The dinitrogenase fraction from the reaction carried out in presence of ATP/dithionite had an EPR spectrum similar to that exhibited by crystalline dinitrogenase from the wild type. Dinitrogenase from the reaction carried out in the absence of the ATP-generating system failed to show the dinitrogenase spectrum. The ratios of acetylene reduction activities and EPR spectrum peak heights at g = 3.65 of crystalline dinitrogenase from the wild type and the enzyme activated by FeMo-co synthesized in vitro were the same. These results suggest that inactive dinitrogenase activated by FeMo-co synthesized in vitro is very similar to native dihitrogenase.
Further Characterization of Protein Factors Involved. All of our FeMo-co synthesis experiments used at least one extract from a mutant strain of A. vinelandii. Attempts to replace the extract of A. vinelandii strain UW45 (NifB-) with K. pneumoniae NifB-strains or generate FeMo-co activity by mixing K. pneumoniae mutant extracts were unsuccessful. Since A. vinelandii is very effective in scavenging molybdenum and it Biochemistry: Shah et al.
synthesizes a Mo-storage protein even during growth in a medium containing ammonium (7, 29) , it seemed possible that this protein was the essential factor from A. vinelandii extracts. However, addition of the extracts of A. vinelandii wild type (grown in ammonium-containing medium) to K. pneumoniae NifB-+ NifN-or NifB-+ NifE-complementation assays failed to generate any FeMo-co activity. Further, addition of the extracts ofA. vinelandii wild type (grown in ammonium-containing medium) to K. pneumoniae NifB-+ UW45 complementation reaction did not significantly stimulate/inhibit FeMo-co synthesis. Thus, the enzyme/ factor contributed by the extracts of A. vinelandii mutant strains is not synthesized constitutively but its synthesis is dependent upon derepressing conditions. In K. pneumoniae, dinitrogenase activity can be restored by the addition of molybdate to Mo-starved cells in the absence of protein synthesis (7, 35) . Our attempts to activate the inactive dinitrogenase by molybdate and ATP in extracts of Mostarved K. pneumoniae wild type were unsuccessful. It is possible that some enzyme, such as the nifQ gene product, involved in the processing of molybdate is very labile in K. pneumoniae and is inactivated during preparation of extracts.
A. vinelandii mutant strain UW111 synthesizes inactive dinitrogenase that can be activated in vitro by the addition of FeMo-co. Extracts of strain UW111 generated Mo-dependent FeMo-co activity when mixed with extracts of strain UW45. These data suggest that mutation in strain UW111 is not in the nifB gene but possibly in the nifN or nifE gene.
Addition of UW111 extracts to K. pneumoniae NifB-, NifN-, or NifE-extracts failed to generate Mo-dependent FeMo-co activity. Addition of UW111 extracts to NifB-+ NifN-or NifB-+ NifE-complementation reactions also failed to generate any FeMo-co activity. From these data it seems that nifEN enzyme product (possibly Mo-free FeMoco precursor) accumulates in A. vinelandii strain UW45 but not in K. pneumoniae NifB-mutants. The reasons for inability of K. pneumoniae extracts to generate Mo-dependent FeMo-co activity in vitro should become apparent as more precise information on the reactions involved becomes available.
FeMo-co synthesis in vitro provides a method to assay the products of nifB, nifQ, and nifV genes, and possibly niJEN enzyme product. It may be possible to assay one or more of these gene products individually by measuring ATPase activity, since FeMo-co biosynthesis requires ATP. Once the gene products involved in FeMo-co biosynthesis are purified, it will be possible to synthesize FeMo-co by using a completely defined system. We thank C. Felix 
